« Back
Home /
Atractylenolide III

Atractylenolide III

Item no.	TMO-T3902-200mg
Manufacturer	TargetMol
CASRN	73030-71-4
Amount	200mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Purity	0,9982
Formula	C15H20O3
Smiles	CC1=C2C[C@H]3C(=C)CCC[C@]3(C)C[C@]2(O)OC1=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Apoptosis
Available
Bioactivity	Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
Molwt	248, 322
Pathway	Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 200mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail